Stockscreener 앱 받기
9.11
1.19%
-0.11
시간 외 거래:
9.11
Avadel Pharmaceuticals Plc 주식(AVDL)의 최신 뉴스
ProShare Advisors LLC Has $322,000 Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals plc (AVDL) Showcases LUMRYZ Success with 14 Abstracts, 4 Oral Presentations at SLEEP 2025 - Insider Monkey
Avadel Pharmaceuticals to Present New Data on LUMRYZ™ (sodium oxybate) For Extended-Release Oral Suspension at SLEEP 2025 - The Manila Times
Wall Street Analysts Think Avadel (AVDL) Could Surge 97.68%: Read This Before Placing a Bet - Yahoo Finance
Avadel Pharmaceuticals to Present at the Jefferies Global Healthcare Conference - TradingView
BNP Paribas Financial Markets Buys Shares of 23,292 Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $553,000 Stock Holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Ameriprise Financial Inc. Lowers Stock Holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Given Average Recommendation of “Buy” by Brokerages - Defense World
Cetera Investment Advisers Sells 24,747 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel wins appeal to expand LUMRYZ trials beyond narcolepsy By Investing.com - Investing.com Nigeria
Jazz Pharmaceuticals: One Step Forward, One Back (NASDAQ:JAZZ) - Seeking Alpha
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Shares Bought by Northern Trust Corp - Defense World
Chesterfield pharmaceutical company adds C-suite role - The Business Journals
All You Need to Know About Avadel (AVDL) Rating Upgrade to Buy - Yahoo Finance
Avadel Pharmaceuticals: Moving Nicely Through An 'Inflection Year' (NASDAQ:AVDL) - Seeking Alpha
Price T Rowe Associates Inc. MD Acquires 6,445 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals appoints Susan Rodriguez as COO - MSN
AVDL Boosts Leadership with New COO Appointment | AVDL Stock News - GuruFocus
Avadel Pharmaceuticals Expands Leadership Team with Appointment of Susan Rodriguez as Chief Operating Officer - The Manila Times
Avadel appoints new COO to boost narcolepsy drug growth By Investing.com - Investing.com Canada
Avadel Pharmaceuticals Appoints New Chief Operating Officer - TipRanks
Avadel appoints new COO to boost narcolepsy drug growth - Investing.com
Avadel Pharmaceuticals Expands Leadership Team With Appointment Of Susan Rodriguez As Chief Operating Officer - marketscreener.com
Avadel Pharmaceuticals to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference - The Manila Times
Earnings Estimates Moving Higher for Avadel (AVDL): Time to Buy? - Yahoo Finance
Wall Street Analysts Believe Avadel (AVDL) Could Rally 100.21%: Here's is How to Trade - Yahoo Finance
Leerink Partnrs Issues Positive Estimate for AVDL Earnings - Defense World
Equities Analysts Set Expectations for AVDL Q4 Earnings - Defense World
Analysts Are Updating Their Avadel Pharmaceuticals plc (NASDAQ:AVDL) Estimates After Its First-Quarter Results - Yahoo Finance
Needham & Company LLC Reaffirms “Buy” Rating for Avadel Pharmaceuticals (NASDAQ:AVDL) - Defense World
Avadel Pharma gains after appeals court ruling in Lumryz case with Jazz Pharma - MSN
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q1 2025 Earnings Call Transcript - Insider Monkey
Avadel Pharmaceuticals (NASDAQ:AVDL) Shares Gap Up Following Strong Earnings - Defense World
First Trust Advisors LP Grows Stock Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
AVDL: Needham Reiterates Buy Rating with $19 Price Target | AVDL Stock News - GuruFocus
Avadel Pharmaceuticals Sees Strong Q1 Growth, Raises Guidance - TipRanks
Avadel: Q1 Earnings Snapshot - CT Insider
Transcript : Avadel Pharmaceuticals plc, Q1 2025 Earnings Call, May 07, 2025 - marketscreener.com
Appeals court reverses-in-part, vacates-in part ruling in Avadel-Jazz fight - Yahoo Finance
AVADEL PHARMACEUTICALS PLC SEC 10-Q Report - TradingView
Avadel Pharmaceuticals Reports First Quarter 2025 Financial Results and Raises Guidance - The Manila Times
Avadel Pharma earnings beat, revenue fell short of estimates By Investing.com - Investing.com UK
Envestnet Asset Management Inc. Sells 32,618 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals Q1 2025 Earnings Call Transcript - MarketBeat
Avadel Pharmaceuticals (AVDL) Wins Court Victory for LUMRYZ Expa - GuruFocus
Avadel Pharmaceuticals (AVDL) Rises After Court Victory - GuruFocus
Federal Circuit Alters Avadel Pharmaceuticals (AVDL) Court Ruling | AVDL Stock News - GuruFocus
Avadel Pharmaceuticals Wins Court Ruling for LUMRYZ Expansion - TipRanks
Avadel Pharmaceuticals Announces Favorable Ruling In Appeal Of Delaware Court Injunction - marketscreener.com
18.36%
0.52%
자본화:
|
볼륨(24시간):